| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Protogeneia, Inc., Münster, Germany
1Correspondence: Protogenia Research Laboratories, Protogeneia, Inc., Mendelstr. 11, D-48149 Münster, Germany. E-mail: protogenia{at}technologiehof-ms.de
Cell surface heparan sulfate (HS) influences a multitude of molecules, cell types, and processes relevant to inflammation. HS binds to cell surface and matrix proteins, cytokines, and chemokines. These interactions modulate inflammatory cell maturation and activation, leukocyte rolling, and tight adhesion to endothelium, as well as extravasation and chemotaxis. The syndecan family of transmembrane proteoglycans is the major source of cell surface HS on all cell types. Recent in vitro and in vivo data suggest the involvement of syndecans in the modulation of leukocyte–endothelial interactions and extravasation, the formation of chemokine and kininogen gradients, participation in chemokine and growth factor signaling, as well as repair processes. Thus, the complex role of HS in inflammation is reflected by multiple functions of its physiological carriers, the syndecans. Individual and common functions of the four mammalian syndecan family members can be distinguished. Recently generated transgenic and knockout mouse models will facilitate analysis of the individual processes that each syndecan is involved in.
Key Words: cell surface heparan sulfate • leukocyte endothelial interaction • growth factor • chemokine • cytokine
This article has been cited by other articles:
|
|
 |
|
  A M Patterson, A Cartwright, G David, O Fitzgerald, B Bresnihan, B A Ashton, and J Middleton Differential expression of syndecans and glypicans in chronically inflamed synovium Ann Rheum Dis, May 1, 2008; 67(5): 592 - 601. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schouten, W. J. Wiersinga, M. Levi, and T. van der Poll Inflammation, endothelium, and coagulation in sepsis J. Leukoc. Biol., March 1, 2008; 83(3): 536 - 545. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rehm, D. Bruegger, F. Christ, P. Conzen, M. Thiel, M. Jacob, D. Chappell, M. Stoeckelhuber, U. Welsch, B. Reichart, et al. Shedding of the Endothelial Glycocalyx in Patients Undergoing Major Vascular Surgery With Global and Regional Ischemia Circulation, October 23, 2007; 116(17): 1896 - 1906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Vanhoutte, M. W.M. Schellings, M. Gotte, M. Swinnen, V. Herias, M. K. Wild, D. Vestweber, E. Chorianopoulos, V. Cortes, A. Rigotti, et al. Increased Expression of Syndecan-1 Protects Against Cardiac Dilatation and Dysfunction After Myocardial Infarction Circulation, January 30, 2007; 115(4): 475 - 482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sutton, V. Friand, S. Brule-Donneger, T. Chaigneau, M. Ziol, O. Sainte-Catherine, A. Poire, L. Saffar, M. Kraemer, J. Vassy, et al. Stromal Cell-Derived Factor-1/Chemokine (C-X-C Motif) Ligand 12 Stimulates Human Hepatoma Cell Growth, Migration, and Invasion Mol. Cancer Res., January 1, 2007; 5(1): 21 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Brule, N. Charnaux, A. Sutton, D. Ledoux, T. Chaigneau, L. Saffar, and L. Gattegno The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9 Glycobiology, June 1, 2006; 16(6): 488 - 501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Letoha, E. Kusz, G. Papai, A. Szabolcs, J. Kaszaki, I. Varga, T. Takacs, B. Penke, and E. Duda In Vitro and in Vivo Nuclear Factor-{kappa}B Inhibitory Effects of the Cell-Penetrating Penetratin Peptide Mol. Pharmacol., June 1, 2006; 69(6): 2027 - 2036. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Edovitsky, I. Lerner, E. Zcharia, T. Peretz, I. Vlodavsky, and M. Elkin Role of endothelial heparanase in delayed-type hypersensitivity Blood, May 1, 2006; 107(9): 3609 - 3616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Smith Jr., J. Novotny, V. S. Carl, and L. D. Comeau Helicobacter pylori and toll-like receptor agonists induce syndecan-4 expression in an NF-{kappa}B-dependent manner Glycobiology, March 1, 2006; 16(3): 221 - 229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tsuzaka, K. Nozaki, C. Kumazawa, K. Shiraishi, Y. Setoyama, K. Yoshimoto, K. Suzuki, T. Abe, and T. Takeuchi DNA Microarray Gene Expression Profile of T Cells with the Splice Variants of TCR{zeta} mRNA Observed in Systemic Lupus Erythematosus J. Immunol., January 15, 2006; 176(2): 949 - 956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. R. Taylor and R. L. Gallo Glycosaminoglycans and their proteoglycans: host-associated molecular patterns for initiation and modulation of inflammation FASEB J, January 1, 2006; 20(1): 9 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Haynes III, F. Ruda, J. Oliver, A. N. Hamood, J. A. Griswold, P. W. Park, and K. P. Rumbaugh Syndecan 1 Shedding Contributes to Pseudomonas aeruginosa Sepsis Infect. Immun., December 1, 2005; 73(12): 7914 - 7921. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Frevert and P. L. Sannes Matrix proteoglycans as effector molecules for epithelial cell function Eur. Respir. Rev., December 1, 2005; 14(97): 137 - 144. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Schmidt, F. Echtermeyer, A. Alozie, K. Brands, and E. Buddecke Plasmin- and Thrombin-accelerated Shedding of Syndecan-4 Ectodomain Generates Cleavage Sites at Lys114-Arg115 and Lys129-Val130 Bonds J. Biol. Chem., October 14, 2005; 280(41): 34441 - 34446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Solic, J. Wilson, S. J. Wilson, and J. K. Shute Endothelial Activation and Increased Heparan Sulfate Expression in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 1, 2005; 172(7): 892 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Eto, I. Kojima, N. Uesugi, R. Inagi, T. Miyata, T. Fujita, R. J. Johnson, S. J. Shankland, and M. Nangaku Protection of Endothelial Cells by Dextran Sulfate in Rats with Thrombotic Microangiopathy J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2997 - 3005. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Tkachenko, J. M. Rhodes, and M. Simons Syndecans: New Kids on the Signaling Block Circ. Res., March 18, 2005; 96(5): 488 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Freeman, L. Liu, M. G. Banwell, K. J. Brown, A. Bezos, V. Ferro, and C. R. Parish Use of Sulfated Linked Cyclitols as Heparan Sulfate Mimetics to Probe the Heparin/Heparan Sulfate Binding Specificity of Proteins J. Biol. Chem., March 11, 2005; 280(10): 8842 - 8849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kwong, R. A. Vaishnav, Y. Liu, N. Subhedar, A. J. Stromberg, M. L. Getchell, and T. V. Getchell Target ablation-induced regulation of macrophage recruitment into the olfactory epithelium of Mip-1{alpha}-/- mice and restoration of function by exogenous MIP-1{alpha} Physiol Genomics, December 15, 2004; 20(1): 73 - 86. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gingis-Velitski, A. Zetser, V. Kaplan, O. Ben-Zaken, E. Cohen, F. Levy-Adam, Y. Bashenko, M. Y. Flugelman, I. Vlodavsky, and N. Ilan Heparanase Uptake Is Mediated by Cell Membrane Heparan Sulfate Proteoglycans J. Biol. Chem., October 15, 2004; 279(42): 44084 - 44092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Elenius, M. Gotte, O. Reizes, K. Elenius, and M. Bernfield Inhibition by the Soluble Syndecan-1 Ectodomains Delays Wound Repair in Mice Overexpressing Syndecan-1 J. Biol. Chem., October 1, 2004; 279(40): 41928 - 41935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Seagal, N. Leider, G. Wildbaum, N. Karin, and D. Melamed Increased plasma cell frequency and accumulation of abnormal syndecan-1plus T-cells in Ig{micro}-deficient/lpr mice Int. Immunol., September 1, 2003; 15(9): 1045 - 1052. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
